$CLOQ
CYBERLOQ TECHNOLOGIES, INC.

2024 Q1 Form 10-Q Financial Statement

#000149315224019806 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q1
Revenue $15.00K $993.00
YoY Change 1410.57% 231.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.711K $3.548K
YoY Change 60.96% -98.71%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $211.0K $97.71K
YoY Change 115.99%
Operating Profit -$196.0K -$96.71K
YoY Change 102.7% -64.95%
Interest Expense -$341.2K -$59.80K
YoY Change 470.57% 570.4%
% of Operating Profit
Other Income/Expense, Net -$341.2K -$59.80K
YoY Change 470.58% 121.43%
Pretax Income -$537.2K -$156.5K
YoY Change 243.26% -48.33%
Income Tax
% Of Pretax Income
Net Earnings -$537.2K -$156.5K
YoY Change 243.26% -48.33%
Net Earnings / Revenue -3581.59% -15761.63%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 119.7M shares
Diluted Shares Outstanding 125.4M shares 119.8M shares

Balance Sheet

Concept 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $127.2K $18.67K
YoY Change 581.04% -64.52%
Cash & Equivalents $127.1K $18.67K
Short-Term Investments
Other Short-Term Assets $68.73K $31.85K
YoY Change 115.79% -77.05%
Inventory
Prepaid Expenses
Receivables $25.00K
Other Receivables $0.00
Total Short-Term Assets $220.9K $50.51K
YoY Change 337.28% -73.61%
LONG-TERM ASSETS
Property, Plant & Equipment $1.189M $451.9K
YoY Change 163.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.189M $451.9K
YoY Change 163.15% 311.27%
TOTAL ASSETS
Total Short-Term Assets $220.9K $50.51K
Total Long-Term Assets $1.189M $451.9K
Total Assets $1.410M $502.5K
YoY Change 180.66% 66.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $55.67K $41.04K
YoY Change 35.65% -48.73%
Accrued Expenses $182.9K $59.07K
YoY Change 209.7% 79.87%
Deferred Revenue $0.00 $0.00
YoY Change
Short-Term Debt $185.0K $185.0K
YoY Change 0.0% -15.91%
Long-Term Debt Due $867.2K $60.01K
YoY Change 1345.16% 4217.27%
Total Short-Term Liabilities $1.291M $345.1K
YoY Change 274.03% -47.78%
LONG-TERM LIABILITIES
Long-Term Debt $30.36K $30.36K
YoY Change 0.0% -71.75%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $30.36K $30.36K
YoY Change 0.0% -88.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.291M $345.1K
Total Long-Term Liabilities $30.36K $30.36K
Total Liabilities $1.321M $375.5K
YoY Change 251.87% -59.7%
SHAREHOLDERS EQUITY
Retained Earnings -$8.797M -$7.390M
YoY Change 19.04%
Common Stock $125.4K $120.2K
YoY Change 4.37%
Preferred Stock
YoY Change
Treasury Stock (at cost) $50.00K $50.00K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $88.97K $127.0K
YoY Change
Total Liabilities & Shareholders Equity $1.410M $502.5K
YoY Change 180.66% 66.77%

Cashflow Statement

Concept 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$537.2K -$156.5K
YoY Change 243.26% -48.33%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$197.6K -$90.70K
YoY Change 117.82% 2.38%
INVESTING ACTIVITIES
Capital Expenditures $92.46K $168.7K
YoY Change -45.19% -253.52%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$92.46K -$168.7K
YoY Change -45.19% 53.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $100.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $110.0K $274.0K
YoY Change -59.85% 39.23%
NET CHANGE
Cash From Operating Activities -$197.6K -$90.70K
Cash From Investing Activities -$92.46K -$168.7K
Cash From Financing Activities $110.0K $274.0K
Net Change In Cash -$180.0K $14.60K
YoY Change -1333.05% -969.05%
FREE CASH FLOW
Cash From Operating Activities -$197.6K -$90.70K
Capital Expenditures $92.46K $168.7K
Free Cash Flow -$290.0K -$259.4K
YoY Change 11.8% -1317.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
274000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-180026 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
307174 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4067 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
127148 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18667 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
522 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
686 usd
CY2024Q1 CLOQ Beneficial Conversion Feature
BeneficialConversionFeature
10000 usd
CY2023Q1 CLOQ Beneficial Conversion Feature
BeneficialConversionFeature
222500 usd
CY2023Q2 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
50000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
993 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
114774 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
33819 usd
CY2024Q1 us-gaap Officers Compensation
OfficersCompensation
62500 usd
CY2023Q1 us-gaap Officers Compensation
OfficersCompensation
45000 usd
CY2024Q1 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
1718 usd
CY2023Q1 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
556 usd
CY2024Q1 CLOQ Rent Expense
RentExpense
2413 usd
CY2023Q1 CLOQ Rent Expense
RentExpense
2298 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5711 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3548 usd
CY2024Q1 us-gaap Supplies Expense
SuppliesExpense
2537 usd
CY2023Q1 us-gaap Supplies Expense
SuppliesExpense
1145 usd
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
21382 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
11341 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
211035 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
97707 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-196035 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-96714 usd
CY2024Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
50773 usd
CY2023Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
11997 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
290431 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
47802 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-341204 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-59799 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-537239 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-156513 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
125439756 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125439756 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
119823087 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119823087 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
16986 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
44000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
222500 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-156513 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
126973 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25250 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
275000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-213727 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
213496 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
275000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-282697 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
215799 usd
CY2023Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
70000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
5000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
520000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-373593 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
437206 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
437206 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
100000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
79000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
10000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-537239 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-537239 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
88967 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
88967 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-537239 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-156513 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
290431 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
47802 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
79000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15000 usd
CY2024Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
24167 usd
CY2023Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-21966 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-40838 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-15284 usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
50251 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
11329 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-197562 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-90700 usd
CY2024Q1 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
91264 usd
CY2023Q1 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
168700 usd
CY2024Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1200 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-92464 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-168700 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
44000 usd
CY2024Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
10000 usd
CY2023Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
230000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
110000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14600 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_z5ea3Zq4Mgak" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the year reported. Actual results may differ from these estimates. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd
CY2020 us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
321725 usd
CY2024Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q1 us-gaap Advertising Expense
AdvertisingExpense
0 usd
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
0 usd
CY2024Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2023 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
68500000 shares
CY2023 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
68000000 shares
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1189291 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1096827 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8796891 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-537239 usd
CY2022Q1 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
10000 shares
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
10 usd
CY2022Q1 us-gaap Severance Costs1
SeveranceCosts1
50000 usd
CY2022Q1 CLOQ Gain Loss On Severance Costs
GainLossOnSeveranceCosts
18076 usd
CY2022Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
500000 shares
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
50000 usd
CY2022Q1 us-gaap Litigation Reserve
LitigationReserve
490000 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
850000 shares
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
79000 usd
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
500000 shares
CY2024Q1 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
50000 usd
CY2023Q2 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
100000 usd
CY2023Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q3 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
50000 usd
CY2023Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q3 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
30000 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
35000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
35000 usd
CY2024Q1 us-gaap Convertible Subordinated Debt Current
ConvertibleSubordinatedDebtCurrent
840000 usd
CY2023Q4 us-gaap Convertible Subordinated Debt Current
ConvertibleSubordinatedDebtCurrent
840000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
150000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
150000 usd
CY2024Q1 us-gaap Debt Instrument Payment Terms
DebtInstrumentPaymentTerms
required payments of $5,000 on or before June 10, 2019, $5,000 on or before August 10, 2019 and the remainder due by the extended due date of September 15, 2019
CY2022Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2022Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
30000 usd
CY2022Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2022Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
30000 usd
CY2023Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
42500 usd
CY2023Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
10000 usd
CY2023Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
100000 usd
CY2023Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
50000 usd
CY2023Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
20000 usd
CY2023Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q2 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
50000 usd
CY2023Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q3 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
45000 usd
CY2023Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q3 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
150000 usd
CY2023Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
50000 usd
CY2023Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
50000 usd
CY2023Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
60000 usd
CY2023Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
15000 usd
CY2023Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
15000 usd
CY2023Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
10000 usd
CY2023Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
10000 usd
CY2023Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2023Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
300000 usd
CY2024Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.02
CY2024Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
10000 usd

Files In Submission

Name View Source Status
0001493152-24-019806-index-headers.html Edgar Link pending
0001493152-24-019806-index.html Edgar Link pending
0001493152-24-019806.txt Edgar Link pending
0001493152-24-019806-xbrl.zip Edgar Link pending
cloq-20240331.xsd Edgar Link pending
ex3-4i.htm Edgar Link pending
ex3-4i_001.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
cloq-20240331_cal.xml Edgar Link unprocessable
cloq-20240331_def.xml Edgar Link unprocessable
cloq-20240331_lab.xml Edgar Link unprocessable
cloq-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending